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Abstract
Background: Despite major improvements in child survival rates, the number of deaths due to diarrhea remains
unacceptably high. We aimed to describe diarrhea-associated mortality and evaluate risk factors for death among
Mozambican children with moderate-to-severe diarrhea (MSD).
Methods: Between December 2007 and November 2012, children under-five with MSD were enrolled in Manhiça
district, as part of the Global Enteric Multicenter study (GEMS). Clinical, epidemiological, and socio-demographic
characteristics were collected. Anthropometric measurements were performed and stool samples collected upon
recruitment. A follow-up visit ~ 60 days post-enrolment was conducted and verbal autopsies performed in all death
cases.
Results: Of the 916 MSD-cases analyzed; 90% (821/916) completed 60 days follow-up and 69 patients died. The
case fatality rate at follow-up was 8% (69/821), and the mortality rate 10.2 (95%CI: 7.75–13.59) deaths per 1000
persons-week at risk. Nearly half of the deaths 48% (33/69) among study participants clustered within 2 weeks of
the onset of diarrhea.
Typical enteropathogenic Escherichia coli (typical EPEC) and Cryptosporidium were the two pathogens associated to
an increased risk of death in the univariate analysis with (HR = 4.16, p = 0.0461) and (H = 2.84, p = 0.0001)
respectively. Conversely, Rotavirus infection was associated to a decreased risk of death (HR = 0.52, p = 0.0198).
According to the multivariate analysis, risk factors for death included co-morbidities such as malnutrition (HR = 4.13,
p < 0.0001), pneumonia/lower respiratory infection (HR = 3.51, p < 0.0001) or invasive bacterial disease (IBD) (HR = 6.
80, p = 0.0009), presenting on arrival with lethargy or overt unconsciousness (HR = 1.73, p = 0.0302) or wrinkled skin
(HR = 1.71, p = 0.0393), and cryptosporidium infection (HR = 2.14, p = 0.0038).
When restricting the analysis to those with available HIV results (n = 191, 22% of the total study sample), HIV was
shown to be a significant risk factor for death (HR = 5.05, p = 0.0009).
Verbal autopsies were conducted in 100% of study deaths, and highlighted diarrhea as the main underlying cause
of death 39%, (27/69); followed by HIV/AIDS related deaths 29.0% (20/69) and sepsis 11.6% (8/69).
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Conclusion: Preventive strategies targeting Cryptosporidium, malnutrition and early identification and treatment of
associated co-morbidities could contribute to the prevention of the majority of diarrhea associated deaths in
Mozambican children.
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Background
In spite of very significant decreasing trends in the last
three decades, childhood mortality remains unacceptably
high globally, with 5.6 million children dying every year
before reaching their 5th birthday, the majority of which
in low and middle-income countries (LMIC) [1]. Diar-
rheal diseases still represent a major cause of morbidity
and mortality in childhood, and are believed to account
for 499,000–526,000 annual child deaths, nearly 9% of
all under five global mortality [2, 3], in spite of the good
intake of life-saving interventions such as oral rehydra-
tion solution (ORS) [3] and the rotavirus vaccine [4].
Deaths in sub-Saharan Africa and Southeast Asia ac-
count for ~ 78% of deaths due to diarrhea worldwide [5,
6], underscoring the inequities related to this particular
syndrome.
The Global Enteric Multi-center Study (GEMS) re-
ported that most episodes of moderate-to-severe diar-
rhea (MSD) among children under 5 years old were
primarily due to four pathogens: Rotavirus, Cryptospor-
idium, Enterotoxigenic Escherichia coli (ST-ETEC), and
Shigella [7]. The risk of dying from diarrheal disease was
reported to be higher among children younger than 2
years of age, albeit with relatively different rates from
one region to another [7]. The advent of the HIV/AIDS
pandemic has also changed the incidence [8], clinical
presentation and outcome of diarrheal diseases, as the
immunosuppression derived from the infection favors a
higher incidence of gastrointestinal infections, not only
from “classical” diarrhea pathogens, but also from more
aggressive opportunistic infections, typical of the im-
munocompromised host. This has resulted in significant
changes in the last decades in the spectrum, clinical
presentation, duration and prognosis of diarrheal epi-
sodes in those countries where HIV is highly prevalent
[9, 10].
Malnutrition is another public health problem in chil-
dren in LMIC, often associated with an increased risk of
mortality and commonly a cause and a consequence of
diarrheal disease. Indeed, diarrhea episodes among mal-
nourished children seem to be more complicated and
prolonged than among non-malnourished children, and
convey a worse prognosis [11–13].
In Mozambique, a paradigmatic example of a
resource-constrained sub-Saharan African country, it
has been estimated that diarrheal diseases are the third
leading cause of death among the pediatric population
(0–14 years), accounting for one out of every 10 deaths
in this age group [14]. Data from the Manhiça district,
in the Southern part of the country, confirm diarrheal
diseases as the third leading cause of hospital admission
among children 0–14 years and the fourth leading cause
of death among children 12–59months of age [15–18].
Significantly, in this same district, both HIV infection
and malnutrition appear to be major public health prob-
lems, with HIV prevalence rates among adults at the
community level peaking at 40% [19], and malnutrition
(of any degree) affecting 47% of all children seen as out-
patients [11].
Despite the significant diarrheal mortality burden, few
studies have assessed the specific risk factors associated
to a fatal outcome in LMIC during the diarrheal epi-
sodes. We propose in this analysis, to determine the pos-
sible risk factors associated to death among children
aged 0–59 months presenting with MSD in Manhiça, a
rural district in southern Mozambique with a high
prevalence of infectious diseases.
Methods
Location of the study
The Manhiça Health Research Centre (CISM) coordi-
nated this study, conducted in six health units in the
District of Manhiça, southern Mozambique, including
five peripheral health posts and the Manhiça District
hospital, which acts as the referral hospital for the entire
Manhiça District. This district, which is part of the wider
Maputo province, is about 80 km north of Maputo, the
countries’ capital. CISM established there in the year
1996 a research institution, which since then has been
running in the district different research platforms, in-
cluding a demographic surveillance system (DSS), cover-
ing when the study was conducted (2007–2012) an
estimated population of around 92,000 inhabitants,
equaling about half of the district’s total population [20].
Previous reports have detailed the idiosyncrasies of the
area [21].
In parallel to the DSS, CISM also established a mor-
bidity surveillance platform at the Manhiça District Hos-
pital (MDH) and other surrounding smaller health posts.
Such platform was designed to passively capture all
pediatric (< 15 years of age) outpatient visits and all ward
hospitalizations [22]. A permanent identification number
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(“perm-ID”), unique to each individual in the study area,
and issued by the DSS, allows the round-the-clock link-
age between the demographic and morbidity platforms.
[23, 24].
The MDH is a busy district hospital which sees around
3500 pediatric admissions annually, and which receives
over 50,000 outpatient visits. It is a 110-bed hospital,
which dedicates 36 of its beds to child hospitalizations.
It also includes a malnutrition specialized hospitalization
unit. The MDH is supported in terms of staffing and re-
sources by CISM. The morbidity platform uses standard-
ized questionnaires for routine data collection, which
collect demographic, clinical, laboratory and outcome
data. Anthropometric measures collected include weight
for all patients, and height/length among hospitalized
patients. A basic microbiology surveillance protocol has
also been ongoing since the year 2003, whereby for all
admitted children under the age of 24 months, a blood
culture is collected. For older children, this is also done
in case of hyperpyrexia (documented temperature > 39°
c), or based on the presence of severity criteria, or to the
admitting clinician’s judgement [25, 26].
Study population and clinical procedures
The Global Enteric Multicenter Study (GEMS) of diar-
rheal disease in infants and young children was con-
ducted in seven diverse, high-burden sites in Asia and
Africa, including Manhiça, in southern Mozambique. In
Manhiça, GEMS recruited patients during a five-year
period (Dec. 2007 to Nov. 2012). GEMS was a
case-control study, stratified by age. It aimed to unravel
the epidemiology and causes of pediatric diarrheal dis-
ease globally and at each of the participating sites. Three
age groups were targeted by the study: infants (0- < 12
months), toddlers (12- < 24months), and older children
(24–- < 60 months). During the 5 years during which the
study was ongoing, study staff screened for diarrhea any
child under the age of five registered in the center’s DSS,
who actively attended any of the participating health
units. The definition for a “diarrhea episode” included
the occurrence of a minimum of three loose stools in
the preceding twenty-four hours.
Diarrheal episodes needed to fulfil a set of inclusion
criteria to be eligible for enrolment as cases, namely that
the episode was new (starting at least after a minimum
of seven days in which the child had not had diarrhea),
acute (shorter than a week since its beginning), or
showed any of the following signs of severity, so as to
fulfil the definition of “moderate-to-severe diarrhea”
(MSD):
a. Variables associated with dehydration: sunken eyes,
decrease in skin turgor (defined by a long [≤2 s] or
very long [> 2 s] abdominal skin pinch recoil),
perceived need or confirmed administration of
parenteral re-hydration,
b. dysentery (stools with discernable blood); or
c. hospitalization because of either diarrhea or
dysentery.
As this was a case-control study, 1 to 3 healthy chil-
dren (with no story of diarrhea in the preceding 7 days)
were randomly selected using the DSS databases from
the Manhiça district matched to the index case by neigh-
borhood, age and gender. Controls were recruited no
later than 2 weeks after the recruitment of each index
case.
The study recorded for all enrolled individuals a var-
iety of clinical (including anthropometric), epidemio-
logical, and socio-demographic information. Fecal
specimens were obtained for pathogen screening and
characterization, following previously published method-
ologies [7]. As Manhiça is a highly HIV-endemic, all
children were actively screened for HIV infection, after
appropriate HIV counseling. This was however only
started in May 2010, when the study had already re-
cruited about a half of the required patients and contin-
ued for all study participants subsequently. Screening
procedures, which followed Mozambican recommenda-
tions, utilized a two-step approach, which included first
a serological screening with the Determine HIV-1/2
Rapid Test (Abbott Laboratories, Abbott Park, IL), with
confirmation for all initially positive cases with a second
serological test (Uni-Gold Rapid Test; Trinity Biotech
Co, Wicklow, Ireland). Molecular confirmation with
DNA PCR was required to confirm HIV positivity in
those children under the age of 18 months with positive
HIV serology. This confirmation was not required for
children above the age of 18 months which were positive
with serology.
The GEMS protocol included a follow-up visit at the
families’ household for each enrolled participant, ap-
proximately two months after recruitment (acceptable
range: 49–90 days), with the objective of verifying the
health status and outcome of the diarrheal episode. Up
to a maximum of 3 different contacts were attempted to
trace the children who could not be found during their
60-day visit, after which, if still not found, they were
considered losses to follow-up [7, 27].
In the first three months after study recruitment, any
death occurring among study participants was investi-
gated using the verbal autopsy methodology. The
INDEPTH-modified standard WHO VA questionnaire
was utilized. All VA questionnaires were individually
reviewed by two clinicians, and discrepant diagnoses
were adjudicated by an expert cause of death reviewer
(QB). Of note, each clinician could attribute up to a
maximum of two plausible causes of death. The final
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CoD diagnosis was reached when there was agreement
in either one or both of the diagnoses between the two
reviewer’s and/or the adjudicator. Cases in which at least
two of the reviewing clinicians considered the CoD diag-
nosis to be “unknown” were considered undetermined.
When two different final diagnoses were assigned for a
given death, each of these was individually mapped onto
ICD-10 in order to calculate cause-specific rates.
Data management and statistical analysis
All data were collected using specific questionnaires,
which were reviewed locally prior to being scanned and
transferred to a centralized Data Collection Centre
(DCC), in the US. Queries were issued centrally, but re-
solved locally, based on the revision of the original
source documents stored on site. Stata/SE software (ver-
sion 14.0, [28] and the package coxphf from R version
3.1.1 were utilized for data analyses [29, 30]. In order to
estimate measures of disease burden such as
diarrhea-associated mortality Rates in children, popula-
tion weights based on sampling weights were calculated.
Mortality analyses were performed for MSD cases.
Any death occurring during the period from recruitment
to the day 60 follow-up visit was considered a study
death. Time to death (or censoring) was calculated as
the time span between the beginning of the diarrhea epi-
sode (first day of diarrhea, defined as the date of recruit-
ment minus the duration of diarrhea at that moment)
and the date of death (or the 60-day visit). Kaplan-Meier
survival curves were estimated, and the difference be-
tween age groups was assessed by weighted-Cox regres-
sion estimation. Mortality Rates and appropriate centiles
of survival time were also described (centiles in accord-
ance to estimated survival curves).
Cox regression with Firth’s Penalized Likelihood ad-
justed for age [31, 32] was used to estimate the associa-
tions between the different covariates (including clinical
characteristics, nutrition practices, breastfeeding and
pathogens detected) and time-to-death. Multivariable
models were estimated by a forward-stepwise procedure,
with p-to-enter and p-to-leave both equal to 0.05 ac-
cording to the Wald test. A specific multivariate analysis
was conducted as a sensitivity analysis only among chil-
dren with HIV results available.
In order to get a better understanding of the total
community burden of diarrhea, Health Care Utilization
and Attitudes Surveys (HUAS) were repeatedly con-
ducted during the study period to investigate the what
was in the area the proportion of cases usually seeking
care at the different health units in the seven days fol-
lowing the onset of the MSD case (called r). Such sur-
veys were conducted on random samples of children,
twice a year, coinciding with each round of the DSS.
Data from such surveys were pooled and weighted using
the sampling weights (inverse of sampling fraction),
based on the number of children in each age-sex
stratum according to information derived from CISM’s
DSS at the time of the round [7]. After that, the values
of “r” and its variances were estimated for each age
stratum, using Kaplan Meier analysis.
A weighted analysis, as previously described by Som-
merfelt et al [33], was utilized for the extrapolation of
mortality rates to the population levels. Such method
proposes to choose weights so as to make the proportion
of cases in the analysis similar to that of the population
from which the cases are drawn. For the calculation of
weights applicable to controls, the inverse of sampling
fraction within each age stratum was used, according to
the formula: (N-cases in_pop)/controls, where N is the
median population; cases_in pop is the number of cases
in the population estimated by the number of eligible
cases divided by r and controls implies the number of
enrolled controls for that stratum. Weights for cases
were constructed according to the sampling weights ad-
justed for fortnight quote (described above) divided by r.
Ethical considerations
This study, which was conducted under the GEMS
framework, was coordinated by the Center for Vaccine
Development (Baltimore, Maryland, USA) and led by
CISM in Manhiça, in close collaboration and partnership
with the Barcelona institute of Global Health (ISGlobal),
in Spain. All GEMS-related protocols and informed con-
sent documents were reviewed and approved prior to
the initiation of the study by the National Bioethics
Committee for Health of Mozambique (CNBS –
IRB00002657), the ethics committee of the Hospital
Clínic of Barcelona, and The Institutional Review Board
at the University of Maryland. All parents/guardians of
participating children were requested to sign a written
informed consent after adequate information regarding
the study was provided.
Results
The study included data on childhood deaths among
children recruited in Manhiça with MSD, between De-
cember 2007 and November 2012 as part of the GEMS.
We enrolled a total of 916 children with MSD and 90%
(821/916) of them completed the day 60 follow-up home
visit (Fig. 1). Reasons for not completing the 60-day
follow-up were essentially due to either changes of resi-
dence to other areas outside the DSS area, or temporary
absences from their homes coinciding with the 60-day
follow-up visits. In these cases, and according to the
study protocol, children were declared lost to follow-up
if 3 consecutive visits were conducted after day 60 with
no success in finding the child.
Acácio et al. BMC Infectious Diseases          (2019) 19:322 Page 4 of 14
As HIV counseling and testing was only introduced
for study participants in May 2010, HIV data are missing
for many recruited participants (100% for year 1 and 2;
73% for year 3, 36% for year 4 and 16% for year 5). How-
ever, no relevant differences were shown when compar-
ing children with or without HIV available data (data not
shown).
The proportion of children with MSD who were taken
to the hospital within the first 7 days from onset of epi-
sode was 66, 59 and 41% among infants, toddlers and
children, respectively (Fig. 2).
Sixty-nine deaths were detected among study partici-
pants during the study follow-up (recruitment-day up to
last follow-up visit), providing a case fatality rate of 8%
(69/821). The mortality rate after adequately weighting
was 10.2 (95%CI: 7.75–13.59) deaths per 1000
persons-week at risk (PWAR). According to the age group
the mortality rate was 10.9 (95%CI: 7.71–15.90) deaths per
1000 PWAR among infants, 11.9 (95%CI: 7.82–18.81)
deaths per 1000 PWAR among toddlers and 5.9 (95%CI:
1.85–28.55) deaths per 1000 PWAR among children 24–
59months of age (p = 0.5357) (Fig. 3 and Table 1). No dif-
ferences were found in terms of the distribution of deaths
in each age group in relation to time, with 48% (33/69) of
all deaths occurring within the first two weeks after the
onset of the diarrhea episode, of which 25% (17/69) in the
first 7 days, and 23% (16/69) after the first week and be-
fore completing 14 days of onset. In terms of distribution
of deaths according to sex, no significant differences were
observed [deaths among boys 57% (39/69) compared to
43% (30/69) among girls; hazard ratio of death [HR = 1.12
(95%CI: 0.79–1.80, p = 0.6199)].
Microbiologic profile
Pathogens associated with an increased risk of death in
the univariate analysis were Cryptosporidium (HR = 2.84
Fig. 1 Hospital visits due to moderate-to-severe diarrhea among children aged 0–59 months of age within DSS area in Manhiça, Mozambique,
December 2007 – November 2012
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(95%CI: 1.72–4.58, p = 0.0001) and typical EPEC (HR =
4.16 (95%CI: 1.02–38.05, p = 0.0461), with Astrovirus in-
fection (HR = 3.51, 95%CI: 0.97–8.93, p = 0.0545) border-
ing statistical significance. Conversely, cases infected
with Rotavirus were less likely to die due to diarrhea
(HR = 0.52, 95%CI: 0.38–0.90, p = 0.0198) (Table 2).
Clinical characteristics
Univariate associations between clinical characteristics
and time-to-death were also assessed (Table 3). Admis-
sion to hospital implied a higher risk of death (HR 3.53,
95%CI 1.95–7.52, p < 0.0001). The median time of
hospitalization was significantly longer for those who
Fig. 2 Proportion of children who sought health care within 7 days of onset of episode
Fig. 3 Mortality at 60 days follow-up among children 0–59 months of age with diarrhea with estimated median time to death for each age group
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Table 2 Pathogens associated with death due to moderate-to-severe diarrhea in the univariate analysis, in children 0–59 months of
age
Variable Vital child’s status at 60-day visit HR (95%CI) p-value
Alive
n = 752 (%)
Dead
n = 69 (%)
ETEC (any ST) 46/172 (27%) 5/14 (36%) 1.64 (0.52, 4.66) 0.3730
ETEC (LT only) 1/643 (0%) 0/57 (0%) 6.17 (0.04,.) 0.3228
EAEC (aata only) 109/752 (14%) 10/69 (14%) 0.97 (0.47, 1.80) 0.9291
EAEC (aaic only) 64/752 (9%) 4/69 (6%) 0.73 (0.24, 1.71) 0.5107
EAEC (aata/aaic) 37/752 (5%) 1/69 (1%) 0.42 (0.04, 1.53) 0.2242
typical EPEC 45/71 (63%) 14/15 (93%) 4.16 (1.02, 38.05) 0.0461
atypical EPEC 1/178 (1%) 0/20 (0%) 4.28 (0.03, 31.01) 0.4095
Shigella (any) 43/752 (6%) 3/69 (4%) 1.01 (0.27, 2.69) 0.9785
Rotavirus 251/751 (33%) 15/69 (22%) 0.52 (0.285, 0.905) 0.0198
Aeromonas spp 9/752 (1%) 0/69 (0%) 0.63 (0.005,.) 0.7282
Norovirus (all) 30/751 (4%) 1/69 (1%) 0.54 (0.06, 1.99) 0.4207
Adenovirus (40/41) 16/749 (2%) 0/68 (0%) 0.34 (0.003,.) 0.3625
Adenovirus (non 40/41) 10/749 (1%) 1/68 (1%) 1.43 (0.16, 5.45) 0.6483
V. cholerae 01 12/752 (2%) 1/69 (1%) 1.94 (0.21, 8.00) 0.4810
Non-typhoidal Salmonella 7/752 (1%) 0/69 (0%) 0.72 (0.006,.) 0.8107
Cryptosporidium 121/751 (16%) 26/69 (38%) 2.84 (1.72, 4.58) 0.0001
Giardia 133/751 (18%) 10/ 69 (14%) 0.90 (0.433, 1.70) 0.7590
Entamoeba histolytica 75/750 (10%) 9/69 (13%) 1.42 (0.67, 2.69) 0.3292
Campylobacter (all) 35/752 (5%) 2/69 (3%) 0.72 (0.15, 2.09) 0.5978
Astrovirus 10/751 (1%) 3/69 (4%) 3.51 (0.97, 8.93) 0.0545
Sapovirus 12/751 (2%) 0/69 (0%) 0.42 (0.003,.) 0.4870
Helicobacter pylori 28/115 (24%) 0/8 (0%) 0.21 (0.002, 1.79) 0.1894
Ascaris lumbricoides 9/115 (8%) 0/8 (0%) 0.79 (0.006, 7.02) 0.8713
Strongyloides stercoralis 4/115 (3%) 0/8 (0%) 2.06 (0.01, 22.34) 0.6617
Ancylostoma duodenale 2/115 (2%) 0/8 (0%) 9.42 (0.04, 326.81) 0.3067
Necator americanus 2/115 (2%) 0/8 (0%) 9.42 (0.04, 326.81) 0.3067
Acácio et al. BMC Infectious Diseases          (2019) 19:322 Page 7 of 14
died (6.5 days) than for those who survived (4.0 days, p
< 0.0001). Clinical variables on arrival associated to
mortality included, among others, lethargy or impaired
consciousness, fever, signs of dehydration such as loss of
skin turgor and skin pinch, chest indrawing and breath-
ing difficulties, signs associated to malnutrition (“flaky
paint” skin appearance, abnormal hair) and rectal pro-
lapse. Only a small fraction of recruited children 22%
(191/821) had available HIV results, and positivity rate
among these was high 21% (40/191). Among these, HIV
infection was strongly correlated with the risk of death
(HR = 6.04, 95%CI 2.38–16.09, p = 0.0002). Invasive bac-
terial disease (bacteremia in an admitted child) (HR =
17.44, 95%CI 6.43–38.15, p < 0.0001) and pneumonia/
lower respiratory infections (HR = 3.51, 95%CI 2.16–
5.65, p < 0.0001) diagnosed during hospital admission
were co-morbidities strongly associated with a lethal
outcome. Malnourished children had also a significantly
increased risk of dying (HR = 5.66, 95%CI 3.43–9.14, p
< 0.0001). After adjusting for anthropometric character-
istics at enrollment, breastfed children had a lower mor-
tality risk (HR = 0.28, 95%CI 0.13–0.69 for partially
breastfeed children; HR = 0.27, 95%CI 0.11–0.64 for ex-
clusively breastfed children; p = 0.0036)]. Conversely, an
admission diagnosis of dysentery was associated with a
70% reduction in the risk of dying (HR = 0.30, 95%CI
0.08–0.78, p = 0.0112).
Multivariate analysis
Independent risk factors for death in the multivariate
analysis included co-morbidities such as malnutrition
(HR = 4.13, 95%CI: 2.42–6.96; p < 0.0001), pneumonia/
lower respiratory infection (HR = 3.50, 95%CI 2.15–5.67,
p < 0.0001) or invasive bacterial disease (IBD) (HR =
6.80, 95%CI 2.43–15.50, p = 0.0009), presenting on ar-
rival with lethargy or overt unconsciousness (HR = 1.73,
95%CI 1.05–2.90, p = 0.0302) or wrinkled skin (HR =
1.71, 95%CI 1.02–2.84, p = 0.0393), and a diagnosis of
cryptosporidium infection (HR = 2.14, 95%CI 1.28–3.58,
p = 0.0038) (Table 4).
Verbal autopsy cause of death diagnoses
Verbal autopsies were conducted to all 69 deaths docu-
mented in study participants (Additional file 1: Table
S1). Final cause of death (CoD) ascertained by this
method highlighted diarrhea as the main underlying
CoD 39% (27/69), followed by HIV/AIDS related deaths
29% (20/69) and sepsis 12% (8/69).
Discussion
The unprecedented decreases in child mortality that
the world has experienced in the last years is the re-
sult of multiple factors, including significant reduc-
tions in certain major causes of under 5 mortality,
such as childhood diarrhea. Indeed, the last three de-
cades have seen diarrhea deaths dropping down from
the 1.748 million deaths in the year 1990 [34], to the
estimated half a million deaths in 2015 [1]. However,
understanding that good preventive and curative strat-
egies are now widely implemented, diarrhea associated
mortality remains unacceptably high. This study has
highlighted the associated impact of diarrheal disease
in Manhiça, a rural area of Southern Mozambique,
whereby up to 8.4% of the children recruited during a
5-year long period died within the first 2 months after
the episode, yielding a population weighted mortality
rate of 10.2 deaths/1000 persons-week at risk. The
fact that nearly half of all deaths clustered within the
first two weeks after the initiation of the diarrhea epi-
sode is strongly supportive of the significance of this
pathology starting the chain of events leading to
death, rather than other causes. This is also supported
by the cause of death diagnoses provided by the ver-
bal autopsies conducted among all study deaths,
whereby 39% of all deaths were directly attributed to
diarrhea. More work is therefore needed to put in
place better preventive and management tools to spe-
cifically address diarrhea as a syndrome, and also all
its secondary consequences.
This study allows a better understanding of the risk
factors and associated problems that require more atten-
tion in order to address diarrheal mortality in this par-
ticular setting. Independent risk factors for death
identified through this analysis are multifactorial and
can be subdivided in those specifically related to patho-
gens, clinical signs and symptoms, or to concurrent
co-morbidities.
Cryptosporidium was the only pathogen independently
associated with death, even after adjusting for covariates.
This pathogen had already been identified in the GEMS
study as one of the major culprits of excess mortality
among young children with MSD, being Manhiça the
GEMS site where the highest overall prevalence was
found [35], whereby cryptosporidium represented the
second most frequent pathogens associated with MSD
[18]. Infection from this protozoan, that can affect both
immunocompetent but also immunocompromised hosts,
often derives from contact with potentially contaminated
water or food sources. In the absence of a Cryptosporid-
ium vaccine and considering the ineffectiveness of
current treatment strategies in the youngest populations
and the diagnostic challenges posed by this pathogen,
minimizing the overall environmental burden (contami-
nated water/food) needs prioritization. Additionally, and
given the high prevalence of HIV infection in the district
of Manhiça [19], prompt initiation of antiretroviral ther-
apy among those children confirmed to be HIV-infected
may contribute to a reduction in the burden of
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Table 3 Clinical characteristics associated with death due to moderate-to-severe diarrhea in the univariate analysis, in children 0–59
months of age
Variable Vital child’s status at 60-day visit Total Hazar Ratio p-value
Alive Dead
Demographic characteristics
Gender: Femalea 307 / 752 (41%) 30 / 69 (43%) 337 / 821 (41%) 1.127 (0.698, 1.804) 0.6199*
Clinical history before hospital admission
Oralite or orsa 202 / 752 (27%) 24 / 69 (35%) 226 / 821 (28%) 1.404 (0.846, 2.274) 0.1840*
Special milk or infant formulaa 1 / 752 (0%) 0 / 69 (0%) 1 / 821 (0%) 5.277 (0.042,.) 0.3565*
Home remedy/herbal medicationa 138 / 752 (18%) 19 / 69 (28%) 157 / 821 (19%) 1.617 (0.936, 2.684) 0.0832*
No special remedies givena 399 / 752 (53%) 32 / 69 (46%) 431 / 821 (52%) 0.800 (0.497, 1.281) 0.3533*
How long has this episode lastedb 2.00 (2.00) [752] 2.00 (2.00) [69] 2.00 (2.00) [821] 1.117 (0.922, 1.330)c 0.2473*
Describe stoola Simple watery 422 (56%) 48 (70%) 470 (57%) reference 0.0630*
Rice watery stool 12 (2%) 0 (0%) 12 (1%) 0.404 (0.003,.)
Sticky/Mucoid 200 (27%) 18 (26%) 218 (27%) 0.815 (0.465, 1.368)
Bloody 118 (16%) 3 (4%) 121 (15%) 0.281 (0.076, 0.747)
Total 752 (100%) 69 (100%) 821 (100%)
Hospital admission
Child was admitted to hospitala 471 / 752 (63%) 60 / 69 (87%) 531 / 821 (65%) 3.533 (1.858, 7.520) <
0.0001*
Received antibioticsa 413 / 752 (55%) 56 / 69 (81%) 469 / 821 (57%) 3.179 (1.799, 6.035) <
0.0001*
Number of days admittedb 4.00 (3.00) [471] 6.50 (7.00) [58] 4.00 (2.00) [529] 1.103 (1.069, 1.132)c <
0.0001*
Signs/symptoms any time since beginning of episode
Vomiting 3 or more times per daya 363 / 752 (48%) 33 / 69 (48%) 396 / 821 (48%) 0.942 (0.585, 1.512) 0.8037*
Unable to drinka 61 / 752 (8%) 5 / 69 (7%) 66 / 821 (8%) 0.993 (0.367, 2.165) 0.9875*
Fevera 249 / 751 (33%) 31 / 69 (45%) 280 / 820 (34%) 1.620 (1.006, 2.591) 0.0474*
Belly paina 188 / 752 (25%) 19 / 69 (28%) 207 / 821 (25%) 1.162 (0.673, 1.926) 0.5784*
Loss of consciousnessa 9 / 752 (1%) 3 / 69 (4%) 12 / 821 (1%) 4.554 (1.258, 11.556) 0.0248*
Wrinkled skina 195 / 751 (26%) 33 / 69 (48%) 228 / 820 (28%) 2.436 (1.513, 3.912) 0.0003*
Irritable or restlessa 105 / 752 (14%) 8 / 69 (12%) 113 / 821 (14%) 0.812 (0.367, 1.577) 0.5600*
Lethargy or loss of consciousnessa 344 / 750 (46%) 44 / 69 (64%) 388 / 819 (47%) 1.989 (1.233, 3.279) 0.0047*
Convulsiona 29 / 752 (4%) 1 / 69 (1%) 30 / 821 (4%) 0.632 (0.071, 2.335) 0.5514*
Difficulty breathinga 53 / 751 (7%) 14 / 69 (20%) 67 / 820 (8%) 3.182 (1.705, 5.578) 0.0006*
Chest indrawinga 113 / 747 (15%) 18 / 68 (26%) 131 / 815 (16%) 1.948 (1.110, 3.276) 0.0213*
Fast breathinga 171 / 750 (23%) 19 / 69 (28%) 190 / 819 (23%) 1.218 (0.696, 2.055) 0.4784*
Rectal prolapsea 1 / 751 (0%) 2 / 69 (3%) 3 / 820 (0%) 12.096 (2.501,
35.288)
0.0053*
Dehydration and nutritional status
Very thirstya 570 / 750 (76%) 48 / 69 (70%) 618 / 819 (75%) 0.754 (0.459, 1.282) 0.2890*
Drinks poorlya 72 / 751 (10%) 11 / 68 (16%) 83 / 819 (10%) 1.776 (0.894, 3.226) 0.0967*
Sunken eyesa 368 / 751 (49%) 38 / 69 (55%) 406 / 820 (50%) 1.231 (0.769, 1.985) 0.3861*
Loss of skin turgora 208 / 752 (28%) 33 / 69 (48%) 241 / 821 (29%) 2.234 (1.388, 3.586) 0.0011*
Dry moutha 298 / 751 (40%) 37 / 69 (54%) 335 / 820 (41%) 1.680 (1.050, 2.703) 0.0306*
I ntravenous rehydrationa 345 / 752 (46%) 39 / 69 (57%) 384 / 821 (47%) 1.441 (0.895, 2.342) 0.1325*
Skin pincha Normal 529 (70%) 36 (52%) 565 (69%) reference 0.0020*
Slow return (<= 2 s.) 172 (23%) 21 (30%) 193 (24%) 1.690 (0.974, 2.864)
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Table 3 Clinical characteristics associated with death due to moderate-to-severe diarrhea in the univariate analysis, in children 0–59
months of age (Continued)
Very slow (> 2 s.) 51 (7%) 12 (17%) 63 (8%) 3.356 (1.696, 6.203)
Total 752 (100%) 69 (100%) 821 (100%)
Dehydration (at least one of above)a 698 / 752 (93%) 66 / 69 (96%) 764 / 821 (93%) 1.393 (0.549, 5.042) 0.5256*






0.648 (0.554, 0.760)c <
0.0001*
Bipedal edemaa 11 / 752 (1%) 3 / 69 (4%) 14 / 821 (2%) 3.237 (0.891, 8.271) 0.0701*
Abnormal haira 57 / 752 (8%) 18 / 69 (26%) 75 / 821 (9%) 3.827 (2.193, 6.388) <
0.0001*
Skin has ‘flaky paint’ appearancea 9 / 752 (1%) 4 / 69 (6%) 13 / 821 (2%) 4.602 (1.509, 10.721) 0.0108*
Is the child currently
breastfeda
No 150 (24%) 21 (35%) 171 (25%) reference 0.0036*
Partial breastfeeding 297 (47%) 23 (38%) 320 (46%) 0.281 (0.134, 0.597)
Exclusive breastfeeding 190 (30%) 16 (27%) 206 (30%) 0.275 (0.117, 0.641)
Total 637 (100%) 60 (100%) 697 (100%)
Hospital diagnoses/co-morbidities
Dysenterya 120 / 752 (16%) 3 / 69 (4%) 123 / 821 (15%) 0.302 (0.082, 0.786) 0.0112*
Pneumonia/lower resp. infectiona 125 / 752 (17%) 30 / 69 (43%) 155 / 821 (19%) 3.510 (2.162, 5.651) <
0.0001*
Meningitisa 0 / 752 (0%) 1 / 69 (1%) 1 / 821 (0%) 62.693 (6.820,
258.067)
0.0023*




Malariaa 129 / 752 (17%) 10 / 69 (14%) 139 / 821 (17%) 0.878 (0.430, 1.619) 0.6920*
Malnutritiona 63 / 752 (8%) 26 / 69 (38%) 89 / 821 (11%) 5.658 (3.439, 9.140) <
0.0001*
HIVa Tested negative 144 (19%) 7 (10%) 151 (18%) reference 0.0019*
Tested positive 30 (4%) 10 (14%) 40 (5%) 6.041 (2.384, 16.090)
Untested pre-May2010 507 (67%) 48 (70%) 555 (68%) 1.789 (0.882, 4.200)
Untested from May2010
onwards
71 (9%) 4 (6%) 75 (9%) 1.155 (0.327, 3.629)
Total 752 (100%) 69 (100%) 821 (100%)




dArithmetic Mean (SD) [n]
Table 4 Independent risk factors associated to death in cases with Moderate-to-severe diarrhea (MSD (Multivariate analysis)
Variable Hazard Ratio 95% Conf. Interval p-value(*)
Age (months)(a) 0.995 (0.963, 1.023) 0.7433
Malnutrition 4.132 (2.428, 6.877) < 0.0001
Pneumonia/lower resp. infection 3.515 (2.158, 5.682) < 0.0001
Invasive bacterial disease (IBD) 6.804 (2.435, 15.516) 0.0009
Cryptosporidium 2.142 (1.289, 3.487) 0.0038
Lethargy or loss of consciousness 1.730 (1.054, 2.903) 0.0300
Wrinkled skin 1.712 (1.027, 2.846) 0.0395
*Cox Regression with Firth’s Penalized Likelihood adjusted for age and CI based on the Profile Penalized-Log Likelihood
aHazard Ratio is the relative change in Hazard per one month increase in age
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Cryptosporidium infections, understanding that this is
another well characterized risk factor for cryptosporidi-
osis [36].
The presence of an Astrovirus infection appeared as an
independent risk factor for death in the multivariate ana-
lysis restricted to children with available HIV data, the
association being borderline significant (HR 3.5, p =
0.0545) in the univariate analysis of the entire popula-
tion. Although numbers are relatively small, more atten-
tion should be drawn to this particular pathogen, that
has already demonstrated a substantial disease burden in
neighboring countries [37], and for which neither cura-
tive nor preventive strategies have been described.
Although rotavirus-associated mortality has clearly
been established globally [38], in this series rotavirus in-
fections appeared to protect against death in the univari-
ate analysis (HR = 0.5, p = 0.0198), highlighting overall
good course secondary to this pathogen if adequate hy-
dration measures are promptly started at the community
of health system level.
Being admitted to hospital appeared as a risk factor
for a poorer outcome. This is hardly surprising, consid-
ering that those patients with MSD requiring admission
are those with higher severity, and with a major risk of
co-morbidities [39], and that health care utilization in
cases of MSD in this study was high. In terms of signs
and symptoms detected in patients upon admission as-
sociated with a higher risk of death, those related to an
altered consciousness and dehydration were most rele-
vant, together with those suggestive of respiratory dis-
tress and/or nutritional deficiencies. These signs/
symptoms reflect both the real mechanisms by which a
diarrheal episode can become lethal and the typical
complications of MSD. Indeed, guaranteeing an ad-
equate intake of liquids and replacing excessively lost
water and electrolytes during episodes of diarrhea re-
mains the cornerstone strategy to prevent diarrheal asso-
ciated deaths, and was at the basis of the WHO and
UNICEF’s recommendation of promoting Oral Rehydra-
tion Solution (ORS) usage back in the 1970’s [40]. How-
ever, diarrheal episodes can trigger both secondary
infections or the exacerbation of pre-existing conditions,
such as malnutrition, as historically and extensively
demonstrated in the literature [41] and also as con-
firmed in this study, where malnutrition was one of the
strongest risk factors associated with death. Breaking the
vicious circle that can become established between mal-
nutrition and diarrheal diseases will therefore be critical
to address a significant proportion of all MSD deaths in
settings such as Manhiça.
Breast-feeding, especially if this is the only source of
nutrition, has been shown to protect children against
diarrhea in Africa as elsewhere in the developing world
[42]. Previous analyses from this same study showed that
in Manhiça, when controlled by other confounders, the
particular breastfeeding pattern did not seem to protect
against pediatric MSD [18] . Interestingly, and in accord-
ance with the published evidence [43], this analysis has
shown that breastfeeding (either partial or exclusive)
during the first months of life has a significant protective
effect against diarrheal attributable mortality. Our find-
ings reinforce the current WHO recommendations that
encourage exclusive breastfeeding during the first 6
months of life as a vital strategy to prevent infant mor-
tality [44, 45].
A concomitant diagnosis of pneumonia (HR = 3.50,
P < 0.0001) or invasive bacterial disease (HR = 6.79, P =
0.0009), were both clear and independent risk factors for
death, signaling the importance of co-morbidities as trig-
gers of a fatal outcome, and of concomitant antibiotic
treatment as a potential justifiable strategy in patients
with MSD which do not improve rapidly with adequate
rehydration. Importantly, an admission diagnosis of dys-
entery was shown in this analysis to be protective against
death in the univariate analysis (HR = 0.3, P = 0.0112).
Typical pathogens causing dysentery such as Shigella or
Entamoeba histolytica have been shown to cause longer
and more severe diarrheal episodes, with an overall in-
creased risk of associated mortality [46, 47]. Our some-
how counterintuitively finding may be explained by the
early and aggressive administration of antimicrobials in
cases of diarrhea with blood in our setting, which may
have attenuated the impact of this particular type of
diarrheal disease.
In this series, MSD episodes among HIV-infected indi-
viduals carried a much worse prognosis. Although not
even a fourth of all patients had HIV screening results
available, due to the late initiation of this practice during
the study, the prevalence of HIV-infected individuals
among recruited patients was high (21%), and this infec-
tion was clearly recognized as an independent risk factor
in the multivariate analysis restricted to those with HIV
data available. Indeed, HIV infection has been shown to
play a significant role not only in the burden and associ-
ated mortality of MSD, but also in the etiology and epi-
demiology of diarrheal disease among children in
Manhiça [48]. In this respect, in settings such as Man-
hiça with a high HIV prevalence, aggressive and prompt
initiation of antiretrovirals among newly diagnosed HIV
cases should be the pillar upon which basing any strat-
egy destined to reducing the burden of diarrheal deaths.
Similarly, the suitability of exclusive breastfeeding prac-
tices for this particular vulnerable group should also be
strengthened [49].
Limitations
This study has several limitations, starting with the
aforementioned lack of HIV data for all study
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participants, which would have allowed a more precise
characterization of the risk factors for MSD mortality.
This happened because according to the national guide-
lines, HIV testing was not mandatory and required an
additional patient consent; leading to the high propor-
tion of participants without HIV results. However, the
comparison of patients with or without HIV results
available showed no differences (data not shown). This
study failed to evaluate electrolyte or zinc levels among
MSD cases and controls, which could have contributed
to a better understanding of dehydration patterns or to
the enrichment of the evidence supporting zinc supple-
mentation in children with diarrhea. However, several
previous studies have demonstrated the protective effect
of this simple intervention against diarrhea mortality
[50, 51] and its use remains warranted, something that
was not in place in Mozambique during the study
period. In addition, there was also a potential for recall
bias during the administration of verbal autopsy forms
in this study. Causes of death based on verbal autopsies
were determined by physicians, although this method
also has inherent limitations for its subjectivity and low
reliability as described elsewere [52–55]. Finally, this
analysis was conducted with GEM’s original set of
microbiological data, and more recent re-analyses of the
study samples, using more advanced molecular methods,
have evidenced a different distribution of the pathogens
associated to MSD, something that could have poten-
tially altered our own analysis.
Conclusions
By characterizing diarrhea-associated deaths in a large
group of Mozambican children, this study contributed
to enlarging the pool of evidence regarding risk factors
for mortality among pediatric patients with MSD. The
knowledge of these factors can better define those chil-
dren at higher risk of dying as a result of a diarrheal epi-
sode, and thus allow a more targeted and specific
approach to prevent those deaths. In this setting, tar-
geted measures against Cryptosporidium infection and
aggressive management of dehydration, malnutrition and
suspected co-morbidities, together with the promotion
of continuous breastfeeding may help prevent most
deaths due to diarrhea.
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